Recalls / Active ingredient / Suvorexant
Suvorexant
2 FDA drug recalls involving the active ingredient “Suvorexant”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-07-21 | Class II | Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 T | Merck & Co. Inc |
| 2021-03-15 | Class II | Belsomra (suvorexant) tablets 20 mg Each tablet contains 20 mg suvorexant. This package contains 30 Tablets i | Cardinal Health Inc. |